UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 702

Sortiert nach

Pre-emptive post-liver transplant hepatitis C virus treatment with daas: proof of concept from a pilot study

Journal of hepatology, 2017, Vol.66 (1), p.S715-S716

2017

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension

Journal of nephrology, 2015-10, Vol.28 (5), p.615-621

2015

Link zum Volltext

Verfügbarkeit prüfen

Polymethylmethacrylate Membrane and Serum Free Light Chain Removal: Enhancing Adsorption Properties

Blood purification, 2013-01, Vol.35 (2), p.52-58

2013

Link zum Volltext

Verfügbarkeit prüfen

LP51 : Treatment of severe HCV recurrence after liver transplantation with sofosbuvir based regimen: Results of the aisf-sofolt Italian compassionate use program

Journal of hepatology, 2015-04, Vol.62, p.S288-S288

2015

Link zum Volltext

Verfügbarkeit prüfen

Smac127 Has Proapoptotic and Anti-Inflammatory Effects on Rheumatoid Arthritis Fibroblast-Like Synoviocytes

Mediators of inflammation, 2016-01, Vol.2016, p.6905678-9

2016

Link zum Volltext

Verfügbarkeit prüfen

Novel concepts for the design of moulds and equipment for expanded polymer bead foams

Progress in additive manufacturing, 2021-05, Vol.6 (2), p.339-346

2021

Link zum Volltext

Verfügbarkeit prüfen

Long‐term outcomes of direct acting antivirals in post‐transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis

Journal of viral hepatitis, 2017-10, Vol.24 (10), p.858-864

2017

Link zum Volltext

Verfügbarkeit prüfen

Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9)

Gynecologic oncology, 2010-10, Vol.119 (1), p.48-52

2010

Link zum Volltext

Verfügbarkeit prüfen

551 DONOR-RELATED CHARACTERISTICS AS PREDICTORS OF SUSTAINED VIROLOGIC RESPONSE TO ANTIVIRAL THERAPY IN RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION

Journal of hepatology, 2011-03, Vol.54, p.S225-S225

2011

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group

Annals of oncology, 2010-01, Vol.21 (1), p.61-66

2010

Link zum Volltext

Verfügbarkeit prüfen

85 INTERACTION BETWEEN CYCLOSPORINE AND RECIPIENT IL-28B RS12979860 C>T GENETIC POLYMORPHISMS IN THE ACHIEVEMENT OF SUSTAINED VIRAL RESPONSE FOR RECURRENT HEPATITIS C

Journal of hepatology, 2012-04, Vol.56, p.S37-S37

2012

Link zum Volltext

Verfügbarkeit prüfen

578 IS THE PRIMARY IMMUNOSUPPRESSIVE DRUG (CYCLOSPORIN A OR TACROLIMUS) PLAYING A ROLE ON THE RESPONSE TO ANTIVIRAL TREATMENT FOR POST-TRANSPLANT HCV RECURRENCE?

Journal of hepatology, 2011-03, Vol.54, p.S235-S235

2011

Link zum Volltext

Verfügbarkeit prüfen

579 THE PRESENCE OF DIABETES REDUCES SVR AFTER ANTIVIRAL THERAPY FOR POST-TRANSPLANT HCV RECURRENCE

Journal of hepatology, 2011-03, Vol.54, p.S236-S236

2011

Link zum Volltext

Verfügbarkeit prüfen

523 PROTRACTED ANTIVIRAL TREATMENT BEYOND CONVENTIONAL TIME LIMITS IMPROVES SURVIVAL IN NON-RESPONDERS TO INTERFERON+RIBAVIRIN ADMINISTERED FOR HCV RECURRENCE AFTER LIVER TRANSPLANTATION

Journal of hepatology, 2011-03, Vol.54, p.S214-S215

2011

Link zum Volltext

Verfügbarkeit prüfen

532 POOR ADHERENCE TO PEGYLATED-INTERFERON AND RIBAVIRIN IS A MAJOR CONCERN IN THE TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION: EVIDENCE FROM THE RECOLT-C GROUP

Journal of hepatology, 2011-03, Vol.54, p.S218-S218

2011

Link zum Volltext

Verfügbarkeit prüfen

Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience

Gynecologic oncology, 2011-05, Vol.121 (2), p.280-284

2011

Link zum Volltext

Verfügbarkeit prüfen

427 TREATMENT OF HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: GENDER ISSUE ON THERAPY OUTCOME

Journal of hepatology, 2011-03, Vol.54, p.S173-S173

2011

Link zum Volltext

Verfügbarkeit prüfen

464 TREATMENT OF THE “UNCOMMON” HCV GENOTYPE 4 INFECTION RECURRENCE AFTER LIVER TRANSPLANTATION. AN ITALIAN MULTICENTRIC EXPERIENCE

Journal of hepatology, 2011-03, Vol.54, p.S189-S189

2011

Link zum Volltext

Verfügbarkeit prüfen

561 BEST MATCHING FOR HCV GENOTYPE 1 LIVER TRANSPLANT RECIPIENTS IS PREDICTED BY HCV1-STAR . A STUDY FROM AISF RECOLT-C DATABASE

Journal of hepatology, 2011-03, Vol.54, p.S229-S229

2011

Link zum Volltext

Verfügbarkeit prüfen

Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer

European journal of nuclear medicine and molecular imaging, 2007-05, Vol.34 (5), p.658-666

2007

Link zum Volltext

Verfügbarkeit prüfen

Prevention strategies in palmar–plantar erythrodysesthesia onset: The role of regional cooling

Gynecologic oncology, 2008-02, Vol.108 (2), p.332-335

2008

Link zum Volltext

Verfügbarkeit prüfen

Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis

International journal of gynecological cancer, 2005-09, Vol.15 (5), p.830-835

2005

Link zum Volltext

Verfügbarkeit prüfen

The prevention of analgesic opioids abuse: expert opinion

European review for medical and pharmacological sciences, 2015-11, Vol.19 (21), p.4203

2015

Link zum Volltext

Verfügbarkeit prüfen

Indirect calorimetry and nutritional problems in clinical practice

Acta diabetologica, 2001, Vol.38 (1), p.1-5

2001

Link zum Volltext

Verfügbarkeit prüfen

Comparison of optimal cytoreduction rates in emergency versus non-emergency admissions for advanced ovarian cancer: A multi-institutional study

European journal of surgical oncology, 2013-08, Vol.39 (8), p.906-911

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 702

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieDigestive And Liver Disease

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(617)
Mit Volltextzugriff
(554)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Pre-emptive post-liver transplant hepatitis C virus treatment with daas: proof of concept from a pilot study

Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension

Polymethylmethacrylate Membrane and Serum Free Light Chain Removal: Enhancing Adsorption Properties

LP51 : Treatment of severe HCV recurrence after liver transplantation with sofosbuvir based regimen: Results of the aisf-sofolt Italian compassionate use program

Smac127 Has Proapoptotic and Anti-Inflammatory Effects on Rheumatoid Arthritis Fibroblast-Like Synoviocytes

Novel concepts for the design of moulds and equipment for expanded polymer bead foams

Long‐term outcomes of direct acting antivirals in post‐transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis

Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9)

551 DONOR-RELATED CHARACTERISTICS AS PREDICTORS OF SUSTAINED VIROLOGIC RESPONSE TO ANTIVIRAL THERAPY IN RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION

Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group

85 INTERACTION BETWEEN CYCLOSPORINE AND RECIPIENT IL-28B RS12979860 C>T GENETIC POLYMORPHISMS IN THE ACHIEVEMENT OF SUSTAINED VIRAL RESPONSE FOR RECURRENT HEPATITIS C

578 IS THE PRIMARY IMMUNOSUPPRESSIVE DRUG (CYCLOSPORIN A OR TACROLIMUS) PLAYING A ROLE ON THE RESPONSE TO ANTIVIRAL TREATMENT FOR POST-TRANSPLANT HCV RECURRENCE?

579 THE PRESENCE OF DIABETES REDUCES SVR AFTER ANTIVIRAL THERAPY FOR POST-TRANSPLANT HCV RECURRENCE

523 PROTRACTED ANTIVIRAL TREATMENT BEYOND CONVENTIONAL TIME LIMITS IMPROVES SURVIVAL IN NON-RESPONDERS TO INTERFERON+RIBAVIRIN ADMINISTERED FOR HCV RECURRENCE AFTER LIVER TRANSPLANTATION

532 POOR ADHERENCE TO PEGYLATED-INTERFERON AND RIBAVIRIN IS A MAJOR CONCERN IN THE TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION: EVIDENCE FROM THE RECOLT-C GROUP

Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience

427 TREATMENT OF HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: GENDER ISSUE ON THERAPY OUTCOME

464 TREATMENT OF THE “UNCOMMON” HCV GENOTYPE 4 INFECTION RECURRENCE AFTER LIVER TRANSPLANTATION. AN ITALIAN MULTICENTRIC EXPERIENCE

561 BEST MATCHING FOR HCV GENOTYPE 1 LIVER TRANSPLANT RECIPIENTS IS PREDICTED BY HCV1-STAR . A STUDY FROM AISF RECOLT-C DATABASE

Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer

Prevention strategies in palmar–plantar erythrodysesthesia onset: The role of regional cooling

Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis

The prevention of analgesic opioids abuse: expert opinion

Indirect calorimetry and nutritional problems in clinical practice

Comparison of optimal cytoreduction rates in emergency versus non-emergency admissions for advanced ovarian cancer: A multi-institutional study

Aktive Filter

Suchergebnisse filtern